Understanding Cancer-Related Fatigue

This study aims to better understand how cancer-related fatigue (CRF) affects cancer survivors and how they talk about it with their doctors. The goal is to create a visual aid, called a CRF Visual Aid, to help improve these conversations and potentially help manage fatigue. Researchers will look at different aspects of your fatigue experience to see what's most important. You might be able to join if you are an adult (18 or older) who has had cancer, finished treatment more than six months ago, have no current signs of cancer, and are experiencing fatigue. The study is currently unclear on its recruitment status and plans to enroll 80 participants.

Study design
This is an observational study that will enroll 80 participants. It is a mixed methods cross-sectional pilot study.
What's involved
You would complete a six-minute walk test, surveys, and two virtual video interviews (45 minutes each). There may also be one additional virtual interview.
Compensation
Not stated in the trial record.
Follow-up
Your experiences with cancer-related fatigue will be measured at seven months from when you start the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06634381

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

Recruiting
Not specifiedAges 18+Observational
Wake Forest University Health Sciences
~80 participants
Updated 2026-07-24 on ClinicalTrials.gov
What's tested:CRF Visual Aid

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Domains reflecting cancer-related fatigue (CRF) experiences in cancer survivors
Measured over Seven months from baseline
Cancer
Fatigue
3 sites across 1 states
North Carolina3
  • Dori Beeler, PhD · PRINCIPAL_INVESTIGATOR · Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ability to comply with study procedures for the duration of the study
Written informed consent and HIPAA authorization for release of personal information
Ability to read/write, understand and converse in English without the need for an interpreter
Men and women aged ≥ 18 years at the time of consent
History of at least one visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC
Completed curative treatment \> 6 months ago for any cancer type, with no detectable evidence of cancer
Self-reported tiredness, exhaustion, or weakness (i.e. fatigue) score of ≥ 4 on the Numerical Rating Scale
Adjuvant endocrine therapy to reduce the risk of cancer returning is acceptable (i.e. tamoxifen or aromatase inhibitors).

Exclusion

Continuing maintenance therapy or other cancer-related treatment (i.e. immunotherapy)
History of or current untreated Major Depressive Disorders or untreated severe depression
Hemoglobin \<11g/dL at last CBC SOC lab collection
History/diagnosis of dementia
Factors or conditions, for which participation may (1) not be in the best interest or (2) interfere with study assessment results (e.g. medical comorbidities, primary brain tumor/metastases)
No access to internet/Wi-Fi
  • Domains reflecting cancer-related fatigue (CRF) experiences in cancer survivorsSeven months from baseline

    A domain is a topic that people talk about that has sub-items characterizing the distinct features and levels of importance within the domain. Using qualitative analysis, evaluation of how survivors think and talk about CRF to generate domain classifications of language. Domain is a categorical variable.